Halozyme Therapeutics HALO
NASDAQ HALO
$110.40 -1.16 (-1.04%)
At close: Sep 30, 2026 · 4:00 PM EDT

Halozyme Therapeutics (HALO) Operating Expenses (2010 - 2026)

Updated

Halozyme Therapeutics (HALO) recorded Operating Expenses of $193.35 million in Q2 2026, up 56.8% from $123.28 million a year earlier and up 0.6% from the prior quarter.

Analysis

Halozyme Therapeutics (HALO) Operating Expenses (2010 - 2026) Analysis & Trends

On a TTM basis, Halozyme Therapeutics' Operating Expenses came in at $1.07 billion as of Jun 30, 2026, up 115.0% year-over-year; for FY2025, it came in at $927.61 million, up 100.0% from FY2024.

  • Annual Operating Expenses has a five-year compound annual growth rate of 49.7% (FY2020 to FY2025).
  • Across earlier years, Operating Expenses came in at $463.85 million in FY2024 (-5.7%), $491.68 million in FY2023 (+25.2%), $392.59 million in FY2022 (+134.5%) and $167.41 million in FY2021 (+35.7%).
  • Quarterly Operating Expenses has ranged from $40.24 million in Q3 2021 to $544.66 million in Q4 2025 over the past five years.
  • On a year-over-year basis, Operating Expenses has increased for six consecutive quarters, with growth averaging 61.2% over the last eight quarters.
  • Peak year-over-year performance for Operating Expenses in the last five years was growth of 344.6% in Q4 2025, against a decline of 9.8% in Q2 2024 at the low end.
  • Per Business Quant, the preceding three quarters came in at $192.19 million (Q1 2026), $544.66 million (Q4 2025) and $136.34 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 10.12 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 10.56 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -9.70 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 18.20 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 2.09 Bn
10 Halozyme Therapeutics 12.59 Bn 11.20 Bn 401.83 Mn 193.35 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 193.35 Mn
Mar 31, 2026 192.19 Mn
Dec 31, 2025 544.66 Mn
Sep 30, 2025 136.34 Mn
Jun 30, 2025 123.28 Mn
Mar 31, 2025 123.33 Mn
Dec 31, 2024 122.51 Mn
Sep 30, 2024 126.89 Mn
Jun 30, 2024 114.12 Mn
Mar 31, 2024 100.34 Mn
Dec 31, 2023 129.00 Mn
Sep 30, 2023 127.75 Mn
Jun 30, 2023 126.58 Mn
Mar 31, 2023 108.34 Mn
Dec 31, 2022 106.99 Mn
Sep 30, 2022 125.68 Mn
Jun 30, 2022 118.31 Mn
Mar 31, 2022 41.61 Mn
Dec 31, 2021 45.47 Mn
Sep 30, 2021 40.24 Mn
API Access

Halozyme Therapeutics Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=HALO&period=max&api_key=YOUR_API_KEY